BTX - Brooklyn Immunotherapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Brooklyn Immunotherapeutics's activity chart (see below) currently has 7 price targets and 7 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 66.67% with an average time for these price targets to be met of 503.67 days.

Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 12-Oct-2022. First documented stock forecast 23-Jan-2019.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 23-Jan-2019

Buy Since 29-Dec-2021

$111.68

Buy Since 18-Mar-2019

$-3.59 (-41.79%)

Show more analysts

What is BTX (Brooklyn Immunotherapeutics) average time for price targets to be met?

On average it took 503.67 days on average for the stock forecasts to be realized with a an average price target met ratio 66.67

Which analyst has the current highest performing score on BTX (Brooklyn Immunotherapeutics) with a proven track record?

RENI BENJAMIN

Which analyst has the current lower performing score on BTX (Brooklyn Immunotherapeutics) with a proven track record?

KRISTEN KLUSKA

Which analyst has the most public recommendations on BTX (Brooklyn Immunotherapeutics)?

Reni Benjamin works at JMP and has 2 price targets and 2 ratings on BTX

Which analyst is the currently most bullish on BTX (Brooklyn Immunotherapeutics)?

Kristen Kluska with highest potential upside - $0

Which analyst is the currently most reserved on BTX (Brooklyn Immunotherapeutics)?

Reni Benjamin with lowest potential downside - -$3.59